<DOC>
	<DOC>NCT01651052</DOC>
	<brief_summary>The purpose of this observational trial is to gather further clinical data to confirm the safety and performance of the Edwards Pericardial Aortic Bioprosthesis, Model 11000 in this trial population.</brief_summary>
	<brief_title>Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000</brief_title>
	<detailed_description>This is a prospective, non-randomized, non-controlled observational clinical trial. Up to 200 subjects will be enrolled at up to 6 participating clinical sites. The trial will include male and female patients, 18 years or older, requiring replacement for a diseased, damaged, or malfunctioning native or prosthetic valve. Patients will be followed and assessed after implant for up to 5 years.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<criteria>18 years or older Require replacement of aortic valve Signed informed consent Willing to return to study site for followup visits Active endocarditis/myocarditis (&lt; 3 months) Myocardial infarction (&lt; 30 days) Renal insufficiency/ Endstage renal disease Life expectancy (&lt; 1 year) Requires multiple valve replacement/repair Requiring emergent aortic valve surgery Pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Aortic valve replacement/regurgitation</keyword>
</DOC>